↓ Skip to main content

The Risks of miRNA Therapeutics: In a Drug Target Perspective

Overview of attention for article published in Drug Design, Development and Therapy, February 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#33 of 2,292)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
155 X users
patent
1 patent

Citations

dimensions_citation
131 Dimensions

Readers on

mendeley
146 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Risks of miRNA Therapeutics: In a Drug Target Perspective
Published in
Drug Design, Development and Therapy, February 2021
DOI 10.2147/dddt.s288859
Pubmed ID
Authors

Song Zhang, Zhujun Cheng, Yanan Wang, Tianyu Han

X Demographics

X Demographics

The data shown below were collected from the profiles of 155 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 146 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 146 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 25 17%
Student > Bachelor 20 14%
Researcher 16 11%
Student > Master 10 7%
Student > Postgraduate 6 4%
Other 12 8%
Unknown 57 39%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 33 23%
Medicine and Dentistry 11 8%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Agricultural and Biological Sciences 6 4%
Chemistry 6 4%
Other 19 13%
Unknown 61 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 98. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2022.
All research outputs
#448,642
of 26,038,372 outputs
Outputs from Drug Design, Development and Therapy
#33
of 2,292 outputs
Outputs of similar age
#13,312
of 540,737 outputs
Outputs of similar age from Drug Design, Development and Therapy
#2
of 59 outputs
Altmetric has tracked 26,038,372 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,292 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 540,737 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.